MoneyWorks4Me

Sanjivani Paranteral informs about scrutinizers report

24 Aug 2026 Evaluate
Further to letter dated 23rd July, 2026, Sanjivani Paranteral has informed that pursuant to Section 110 of the Companies Act, 2013 read with the Companies (Management and Administration) Rules, 2014, the members of the Company have duly approved, through remote e-voting facility the special business as specified in the Postal Ballot Notice dated 23rd July, 2026. The details of the voting results in the format prescribed under Regulation 44(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Scrutinizer’s Report is enclosed. 

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..